These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8049630)

  • 1. The epidemiology of tumor markers in breast cancer management: prognostic markers.
    Page DL
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):101-4. PubMed ID: 8049630
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
    Graeff H; Jänicke F
    Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Prognostic factors" in breast cancer--1].
    Brockmann B; Reitzig P
    Z Arztl Fortbild (Jena); 1994 Feb; 88(2):111-4. PubMed ID: 8147017
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of prognostic factors in evaluation of survival in breast cancer].
    Popârlan T; Muscă S
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):147-51. PubMed ID: 20509292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bel-2 as a prognostic factor of breast cancers].
    Watanabe K; Kawabata K; Ozaki S; Fujita H; Kojima Y; Tsuda H
    Nihon Rinsho; 2000 Apr; 58 Suppl():423-8. PubMed ID: 11026028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognostic factors in breast cancer].
    Jonat W; Eidtmann H; Friedrichs K
    Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
    [No Abstract]   [Full Text] [Related]  

  • 7. Proliferative activity in primary breast carcinomas is a salient prognostic factor.
    Michels JJ; Marnay J; Delozier T; Denoux Y; Chasle J
    Cancer; 2004 Feb; 100(3):455-64. PubMed ID: 14745860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor biology-oriented treatment concepts in gynecologic oncology].
    Graeff H
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):M27-31. PubMed ID: 7665053
    [No Abstract]   [Full Text] [Related]  

  • 9. HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.
    Volpi A; Nanni O; De Paola F; Granato AM; Mangia A; Monti F; Schittulli F; De Lena M; Scarpi E; Rosetti P; Monti M; Gianni L; Amadori D; Paradiso A
    J Clin Oncol; 2003 Jul; 21(14):2708-12. PubMed ID: 12860948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategies for management of axillary lymph nodes in breast cancer. Point of view of the Institut Bergonié. ].
    de Mascarel I; MacGrogan G
    Ann Pathol; 2003 Dec; 23(6):518-33. PubMed ID: 15094590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for breast cancer and their use in the clinical setting.
    Kapoor A; Vogel VG
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent prognostic factors for breast cancer].
    Ikeda T
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):635-43. PubMed ID: 9126298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer.
    Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W
    Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved tumor staging in colorectal cancer.
    Lindblom A
    N Engl J Med; 1998 Jul; 339(4):264-5. PubMed ID: 9673307
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cathepsin D as a prognostic marker in breast cancer].
    Asculai E; Gopas J; Cohen Y
    Harefuah; 1996 Jun; 130(11):787-90. PubMed ID: 8794687
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic tissue criteria of pT1-2, pN0-1, M0 cancers of the breast with a low or moderate metastatic potential].
    Bolla M; Pasquier D; Chédin M; Winckel P; Mousseau M; Berland E; Salvat J; Panh MH; Payan R
    Bull Cancer; 1996 Dec; 83(12):1061. PubMed ID: 9116376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].
    Meng J; Lang RG; Fan Y; Fu L
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):284-8. PubMed ID: 17760256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular prognostic factors for breast cancer metastasis and survival.
    Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
    Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in breast cancer with contralateral supraclavicular or axillary lymphatic metastases].
    Muñoz-González D; Mora-Tizcareño A; Ramírez-Ugalde MT; Pérez-Sánchez M; Sánchez-Valdivieso E; Gómez-Ruiz C; Zeichner-Gancz I
    Rev Invest Clin; 1998; 50(1):25-30. PubMed ID: 9608786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.